
Omar Fueyo
@omar_fueyo
Medicina Interna - CMABC / Nefrología - INCMNSZ
ID: 233830894
04-01-2011 06:15:00
17,17K Tweet
554 Followers
766 Following













#Semaglutide and #tirzepatide have improved #obesity treatment but necessitate careful dosing and lifestyle adjustments to manage gastrointestinal side effects and ensure sustainable weight loss. ja.ma/45r4GGY Jaime Almandoz, MD MBA FTOS





Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases ca. 2024 from ASN Publications #Nephpearls 👉 pubmed.ncbi.nlm.nih.gov/39292519/



